Experts Rebutted In Pfizer's Celebrex Case
A dispute has erupted over proposed testimony in the product liability litigation over pharmaceutical giant Pfizer Inc.'s anti-inflammatory drug Celebrex, with both sides calling on a judge to bar the experts'...To view the full article, register now.
Already a subscriber? Click here to view full article